vs

Side-by-side financial comparison of Akso Health Group (AHG) and Token Cat Ltd (TC). Click either name above to swap in a different company.

Akso Health Group is the larger business by last-quarter revenue ($7.0M vs $2.8M, roughly 2.5× Token Cat Ltd). Token Cat Ltd runs the higher net margin — -3.4% vs -18.6%, a 15.2% gap on every dollar of revenue.

Akso Health Group is a global healthcare enterprise specializing in the R&D, production, and distribution of generic pharmaceuticals, over-the-counter wellness products, and medical devices. It primarily serves markets in China, Southeast Asia, and North America, with core business segments covering drug manufacturing, medical supply chains, and community healthcare services.

AHG vs TC — Head-to-Head

Bigger by revenue
AHG
AHG
2.5× larger
AHG
$7.0M
$2.8M
TC
Higher net margin
TC
TC
15.2% more per $
TC
-3.4%
-18.6%
AHG

Income Statement — Q2 FY2026 vs Q2 FY2025

Metric
AHG
AHG
TC
TC
Revenue
$7.0M
$2.8M
Net Profit
$-1.3M
$-93.0K
Gross Margin
8.9%
79.0%
Operating Margin
-20.5%
-206.9%
Net Margin
-18.6%
-3.4%
Revenue YoY
-37.9%
Net Profit YoY
98.3%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AHG
AHG
TC
TC
Q3 25
$7.0M
Q2 25
$2.8M
Q2 24
$4.4M
Q2 23
$12.7M
Q2 22
$13.3M
Net Profit
AHG
AHG
TC
TC
Q3 25
$-1.3M
Q2 25
$-93.0K
Q2 24
$-5.6M
Q2 23
$-4.2M
Q2 22
$-8.4M
Gross Margin
AHG
AHG
TC
TC
Q3 25
8.9%
Q2 25
79.0%
Q2 24
69.2%
Q2 23
63.4%
Q2 22
81.0%
Operating Margin
AHG
AHG
TC
TC
Q3 25
-20.5%
Q2 25
-206.9%
Q2 24
-146.9%
Q2 23
-59.9%
Q2 22
-49.6%
Net Margin
AHG
AHG
TC
TC
Q3 25
-18.6%
Q2 25
-3.4%
Q2 24
-125.9%
Q2 23
-33.3%
Q2 22
-62.9%
EPS (diluted)
AHG
AHG
TC
TC
Q3 25
Q2 25
Q2 24
Q2 23
Q2 22
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AHG
AHG
TC
TC
Cash + ST InvestmentsLiquidity on hand
$11.1M
$150.0K
Total DebtLower is stronger
$1.4M
Stockholders' EquityBook value
$198.3M
$4.6M
Total Assets
$212.0M
$28.4M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AHG
AHG
TC
TC
Q3 25
$11.1M
Q2 25
$150.0K
Q2 24
$689.0K
Q2 23
$3.0M
Q2 22
$4.8M
Total Debt
AHG
AHG
TC
TC
Q3 25
Q2 25
$1.4M
Q2 24
$1.8M
Q2 23
Q2 22
Stockholders' Equity
AHG
AHG
TC
TC
Q3 25
$198.3M
Q2 25
$4.6M
Q2 24
$-787.0K
Q2 23
$9.1M
Q2 22
$21.4M
Total Assets
AHG
AHG
TC
TC
Q3 25
$212.0M
Q2 25
$28.4M
Q2 24
$12.5M
Q2 23
$25.1M
Q2 22
$40.6M
Debt / Equity
AHG
AHG
TC
TC
Q3 25
Q2 25
0.30×
Q2 24
Q2 23
Q2 22

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AHG
AHG
TC
TC
Operating Cash FlowLast quarter
$1.2M
$-23.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AHG
AHG
TC
TC
Q3 25
$1.2M
Q2 25
$-23.7M
Q2 24
$-1.5M
Q2 23
$-7.2M
Q2 22
$-8.3M
Free Cash Flow
AHG
AHG
TC
TC
Q3 25
Q2 25
Q2 24
$-1.5M
Q2 23
Q2 22
$-8.3M
FCF Margin
AHG
AHG
TC
TC
Q3 25
Q2 25
Q2 24
-34.4%
Q2 23
Q2 22
-62.2%
Capex Intensity
AHG
AHG
TC
TC
Q3 25
Q2 25
Q2 24
0.0%
Q2 23
Q2 22
0.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons